Veritable’s Pfizer PFE Stock Holding History

Veritable’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-244,415	Closed	-$8.97M	–	585
2023 Q2	$8.97M	Sell	244,415 -6,217	-2%	-$242K	0.14%	79
2023 Q1	$10.2M	Sell	250,632 -35,862	-13%	-$1.55M	0.17%	70
2022 Q4	$14.7M	Sell	286,494 -6,537	-2%	-$313K	0.25%	47
2022 Q3	$12.8M	Sell	293,031 -18,333	-6%	-$891K	0.25%	49
2022 Q2	$16.3M	Buy	311,364 +13,068	+4%	+$666K	0.29%	40
2022 Q1	$15.4M	Buy	298,296 +6,597	+2%	+$342K	0.24%	52
2021 Q4	$17.2M	Buy	291,699 +14,913	+5%	+$739K	0.26%	48
2021 Q3	$11.9M	Buy	276,786 +17,042	+7%	+$755K	0.19%	64
2021 Q2	$10.2M	Sell	259,744 -2,596	-1%	-$101K	0.16%	71
2021 Q1	$9.51M	Sell	262,340 -462	-0.2%	-$16.4K	0.16%	72
2020 Q4	$9.67M	Sell	262,802 -27,994	-10%	-$1.03M	0.18%	69
2020 Q3	$10.1M	Sell	290,796 -2,588	-0.9%	-$90.7K	0.2%	68
2020 Q2	$9.1M	Sell	293,384 -10,740	-4%	-$365K	0.2%	65
2020 Q1	$9.42M	Sell	304,124 -11,144	-4%	-$380K	0.23%	61
2019 Q4	$11.7M	Buy	315,268 +4,197	+1%	+$149K	0.22%	66
2019 Q3	$10.6M	Sell	311,071 -3,988	-1%	-$145K	0.21%	70
2019 Q2	$12.9M	Sell	315,059 -6,606	-2%	-$262K	0.26%	55
2019 Q1	$13M	Buy	321,665 +5,813	+2%	+$233K	0.26%	51
2018 Q4	$13.1M	Sell	315,852 -7,416	-2%	-$308K	0.3%	42
2018 Q3	$13.5M	Sell	323,268 -4,465	-1%	-$172K	0.27%	49
2018 Q2	$11.3M	Sell	327,733 -9,533	-3%	-$326K	0.24%	60
2018 Q1	$11.4M	Sell	337,266 -6,225	-2%	-$214K	0.24%	59
2017 Q4	$11.8M	Sell	343,491 -28,284	-8%	-$964K	0.24%	59
2017 Q3	$12.6M	Sell	371,775 -16,190	-4%	-$520K	0.27%	50
2017 Q2	$12.4M	Sell	387,965 -15,391	-4%	-$485K	0.28%	48
2017 Q1	$13.1M	Buy	403,356 +2	+0%	+$63	0.31%	43
2016 Q4	$12.4M	Buy	403,354 +19,394	+5%	+$592K	0.3%	43
2016 Q3	$12.3M	Buy	383,960 +10,595	+3%	+$354K	0.31%	45
2016 Q2	$12.5M	Sell	373,365 -519	-0.1%	-$16.6K	0.32%	44
2016 Q1	$10.5M	Sell	373,884 -17,012	-4%	-$486K	0.27%	51
2015 Q4	$12M	Buy	390,896 +12,885	+3%	+$405K	0.33%	44
2015 Q3	$11.3M	Sell	378,011 -4,624	-1%	-$148K	0.33%	43
2015 Q2	$12.2M	Sell	382,635 -73,108	-16%	-$2.38M	0.33%	38
2015 Q1	$15M	Buy	455,743 +44,670	+11%	+$1.42M	0.31%	46
2014 Q4	$12.1M	Sell	411,073 -503	-0.1%	-$14.4K	0.25%	66
2014 Q3	$11.5M	Sell	411,576 -695	-0.2%	-$19.5K	0.25%	66
2014 Q2	$11.6M	Buy	412,271 +20,289	+5%	+$578K	0.24%	65
2014 Q1	$11.9M	Sell	391,982 -8,766	-2%	-$261K	0.26%	66
2013 Q4	$11.6M	Buy	400,748 +99	+0%	+$2.88K	0.26%	65
2013 Q3	$10.9M	Sell	400,649 -73,821	-16%	-$2.01M	0.26%	67
2013 Q2	$12.6M	Buy	+474,470	New	+$13.1M	0.3%	57

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Veritable's PFE Position: Q3 2023 in Review

Veritable sold out of Pfizer (PFE) in Q3 2023, closing a stake of 244,415 shares — an estimated $8.97M sold.

Veritable first reported a position in PFE in Q2 2013 and held it in 41 quarters. The position peaked at $17.2M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Veritable reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Veritable sold 244,415 Pfizer shares in Q3 2023, an estimated $8.97M.
Veritable first reported a position in Pfizer in Q2 2013 and held it in 41 quarters.
Veritable's Pfizer position peaked at $17.2M in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.